|
PROTEOLYTIC ACTIVATION OF PROTHROMBIN The serine
protease α-thrombin is produced by
proteolytic activation of the zymogen, prothrombin. The enzyme complex,
prothrombinase,
catalyzes the proteolysis of two peptide bonds in
prothrombin, which gives rise to an NH2-terminal
derived F1.2 region and the heterodimer, α-thrombin.
Alpha-thrombin is composed of an "A" chain (Mr=6000) which is covalently linked
to a "B" chain (Mr=31,000) through a single disulfide bond.
PURCHASING
AND PRODUCT INFORMATION
|
Catalog
Number
HCT-0020
HCT-DFP
HCT-FPRCK
HCT-BFPRCK
BCT-1020
BCT-DFP
BCT-FPRCK
BCT-BFPRCK
MCT-5020**
|
Description
Human α-Thrombin
Human α-Thrombin-DFP
Human α-Thrombin-FPRck
(FPR-CMK*)
Human α-Thrombin-BFPRck
(Biotin)
Bovine α-Thrombin
Bovine α-Thrombin-DFP
Bovine α-Thrombin-FPRck
(FPR-CMK*)
Bovine α-Thrombin-BFPRck
(Biotin)
Mouse Thrombin
|
Size
100
µg or 1 mg
100
µg
100
µg
100
µg
200
µg or 1 mg
100
µg
100
µg
100
µg
50
µg |
Formulation
50%
glycerol/water (v/v)
20
mM Hepes, 150 mM NaCl, pH 7.4
20
mM Hepes, 150 mM NaCl, pH 7.4
20
mM Hepes, 150 mM NaCl, pH 7.4
50%
glycerol/water (v/v)
20
mM Hepes, 150 mM NaCl, pH 7.4
20
mM Hepes, 150 mM NaCl, pH 7.4
20
mM Hepes, 150 mM NaCl, pH 7.4
50%
glycerol/water (v/v)
|
|
Storage
Glyercol
formulation: -20oC
Hepes
formulation: -80oC |
Purity
>95%
by SDS-PAGE |
Activity
Determination
Fibrinogen
clotting or chromogenic assay |
Shelf
Life (properly stored)
12
months |
| Compliment
fluorogenic substrate(s):
HTI Catalog # SN-17a,
SN-20, and SN-59 |
DOWNLOAD
THROMBIN PDF |
 |
Sample Gel
Information:
Gel:
Novex 4-12% Bis-Tris
Load:
Human Thrombin, 1 µg per lane
Buffer:
MES
Standard:
SeeBluePlus 2; Myosin (191 kDa), Phosphorylase B (97 kDa), BSA (64
kDa), Glutamic Dehydrogenase (51 kDa), Alcohol Dehydrogenase (39 kDa),
Carbonic Anhydrase (28 kDa), Myoglobin Red (19 kDa), Lysozyme (14
kDa)
|
|
Sample
publications referencing our Thrombin:
-
Rovner,
A, Fagnant, P., Trybus, K., Biochemistry. 2006 April 25;
45(16): 5280–5289. (Fusion Protein Cleavage)
-
Bai,
E., et al., Biochem. J. (2006) 400, 385–392. (Fusion Protein
Cleavage)
-
Lian,
L., et al., Blood. 2005 July 1; 106(1): 110–117. (Platelet
Activation)
-
Nylander,
S., et al., British Journal of Pharmacology (2004) 142,
1325–1331 (Platelet Activation)
-
Bos,
M., et al., Blood. 2009 114:
686-692. (Cleavage of venom factor V from brown snake)
-
Krisinger,
M. et al., FEBS
Journal 276 (2009) 6586–6602. (Activated mouse protein C)
This
publication list is not all encompassing, and is only meant to
provide limited examples of how Haematologic Technologies'
products are used. We encourage you to search the literature
for other examples pertinent to your experimentation, and to
contact us with any technical questions. |
|
U.S.
Pricing |
Product
inquiry |
SAMPLE
DATA SHEET |
ORDER
NOW! |
*
Chloromethylketone
**Due
to mouse plasma quality issues
our mouse proteins are not being sold until further
notice. At the
present time we cannot give a completion date. Thank you..
Overview
of Thrombin
Alpha-thrombin is a highly specific serine protease generated by proteolytic activation of the zymogen
prothrombin (1). During coagulation, thrombin cleaves
fibrinogen to form fibrin, leading to the ultimate step in coagulation, the formation of a fibrin clot. Thrombin is also responsible for feedback activation of the procofactors
factor V and factor VIII. Thrombin has also been reported to activate
factor XIII and platelets, and also functions as a vasoconstrictor protein. The procoagulant activity of thrombin is arrested in two ways: 1) inhibition by either
heparin cofactor II or the
antithrombin III/heparin complex; or 2) complex formation with
thrombomodulin. Formation of the thrombin/thrombomodulin complex results in the inability of thrombin to cleave fibrinogen and activate factors V and VIII, but increases the efficiency of thrombin for activation of the anticoagulant,
protein C.
Thrombin is a two chain enzyme composed of an NH2-terminal "A" chain (Mr=6,000) and a COOH-terminal "B" chain (Mr=31,000) which remain covalently associated through a single disulfide bond. Human thrombin is 13 amino acids shorter than the bovine thrombin due to a thrombin cleavage site on the human protein that is not present in the bovine protein.
Thrombin is also utilized for site specific cleavage of fusion proteins expressed in bacteria (9-11). A thrombin sensitive site is incorporated between the recombinant protein of interest and peptides or proteins which facilitate purification and/or expression. The target protein is released from the expressed hybrid by cleavage with thrombin. Thrombin can then be easily removed by affinity chromatography.
Human, bovine and mouse thrombin are prepared from purified prothrombin using a modification of the Lundblad procedure (1) as described by Nesheim et al. (2). Thrombin is supplied in 50% (vol/vol)
glycerol/H2O and should be stored at
-20oC. Purity is determined by SDS-PAGE analysis and activity is measured in a thrombin specific clotting assay, and compared to standardized NIH thrombin. Thrombin is also available with the active site blocked with either DFP, FPRck, or biotinlyated
FPRck.
Cleavage
of Fusion Proteins
In
addition to its broad application in coagulation research thrombin can be
used for site specific
cleavage of fusion proteins. A thrombin sensitive site is incorporated
between the recombinant
protein of interest and peptides or proteins which facilitate purification
and/or expression. The
target protein is released from the expressed hybrid by cleavage with
thrombin. Thrombin can then be
easily removed by affinity chromatography. Lot to lot consistency ensures
reproducible results every time.
For experiments involving cell cultures, please contact us to discuss
custom, low endotoxin lots designated
for cell culture use.
Properties of
Thrombin
| Localization: |
Plasma |
| Mode of action: |
Serine protease which cleaves fibrinogen to form fibrin; also responsible for
activation of protein C, platelet activation and feedback activation of the
procofactors,
factor V and factor VIII |
| Molecular weight: |
36,700 (3-6) |
| Extinction coefficient: |
| E |
|
= 18.3 (human) (6) |
|
|
= 19.5 (bovine) (7) |
|
| Specific Activity: |
approximately 3800 NIH units/mg |
| Isoelectric point: |
7.0-7.6 (human) (3) |
| Structure: |
two subunits, approximately
Mr=6,000 and 31,000 |
| Percent carbohydrate: |
approximately 5% |
PURCHASING
AND PRODUCT INFORMATION
|
Catalog
Number
HCT-0020
HCT-DFP
HCT-FPRCK
HCT-BFPRCK
BCT-1020
BCT-DFP
BCT-FPRCK
BCT-BFPRCK
MCT-5020
|
Description
Human α-Thrombin
Human α-Thrombin-DFP
Human α-Thrombin-FPRck
(FPR-CMK*)
Human α-Thrombin-BFPRck
(Biotin)
Bovine α-Thrombin
Bovine α-Thrombin-DFP
Bovine α-Thrombin-FPRck
(FPR-CMK*)
Bovine α-Thrombin-BFPRck
(Biotin)
Mouse Thrombin
|
Size
100
µg or 1 mg
100
µg
100
µg
100
µg
200
µg or 1 mg
100
µg
100
µg
100
µg
50
µg |
Formulation
50%
glycerol/water (v/v)
20
mM Hepes, 150 mM NaCl, pH 7.4
20
mM Hepes, 150 mM NaCl, pH 7.4
20
mM Hepes, 150 mM NaCl, pH 7.4
50%
glycerol/water (v/v)
20
mM Hepes, 150 mM NaCl, pH 7.4
20
mM Hepes, 150 mM NaCl, pH 7.4
20
mM Hepes, 150 mM NaCl, pH 7.4
50%
glycerol/water (v/v)
|
|
Storage
Glyercol
formulation: -20oC
Hepes
formulation: -80oC |
Purity
>95%
by SDS-PAGE |
Activity
Determination
Fibrinogen clotting or chromogenic assay |
Shelf
Life (properly stored)
12
months |
| Compliment
fluorogenic substrate(s):
HTI Catalog #
SN-17a,
SN-20, and SN-59 |
DOWNLOAD
THROMBIN PDF |
|
U.S.
Pricing |
Product
inquiry |
SAMPLE
DATA SHEET |
ORDER
NOW! |
*
Chloromethylketone
References
1. Lundblad, R.L., et al., Methods Enzymol., 45, 156 (1976).
2. Nesheim, M.E., et al., J. Biol. Chem., 258, 5386 (1983).
3. Fenton, J.W., et al., in Chemistry and Biology of Thrombin, ed. R.L. Lundblad, J.W. Fenton, K.G. Mann, pp. 43-70. Ann Arbor, MI: Ann Arbor Science Publishers, Inc., 1977.
4. Braughman, D.J., et al., J. Biol. Chem., 242, 5252 (1967).
5. Winzor, D.J., et al., Arch. Biochem. Biophys., 104, 202 (1964).
6. Fenton, J.W., et al., J. Biol. Chem., 252, 3587 (1977).
7. Winzor, D.J., et al., J. Phys. Chem., 68, 338 (1964).
8. Magnusson, S., in The Enzymes, ed. P.D. Boyer, vol. III, pp. 277-321. New York: Academic Press, 1971.
9.Gaun, K.L. and Dixon, J.E., Anal. Biochem., 192, 262 (1991).
10.Germino, J. and Bastia, D., Proc. Natl. Acad. Sci. USA, 81, 4692 (1984).
11.Chang, J.-Y., Eur. J. Biochem., 151, 217 (1985).
|
|
|
© 2009 Haematologic Technologies, Inc. All Rights Reserved |